Similar Articles

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 155

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 158

Anxiety and Depression in Chronic Headache

Deniz SELÇUKİ, Canan YÜCESAN, Nermin MUTLUER, Rana TANRIDAĞ, Gönül OZAN

Issue: 1995, Volume 1 - Issue 3
0 188

Global Aphasia in Left-Sided Hemispheric Stroke

Ali ÖZEREN, Yakup SARICA, Rasim EFE

Issue: 1995, Volume 1 - Issue 2
0 180

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 167

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 287

The lmmunopathogenesis of Multiple Sclerosis

Nihal Işık

Issue: 2009, Volume 15 - Supplement 3
0 253

Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis

Rana KARABUDAK

Issue: 2009, Volume 15 - Supplement 3
0 282

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 214

Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports

Murat TERZİ

Issue: 2009, Volume 15 - Supplement 3
0 286